EGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy
2013 · British Journal of Cancer · 66 citations
https://doi.org/10.1038/bjc.2013.577
K
Kensuke Oikawa
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
1.5K
Citations
22
h-index
38
i10-index
Kensuke Oikawa is an academic researcher from Asahikawa Medical University. The author has contributed to research in topics: Immunotherapy and Immune Responses & Cancer Immunotherapy and Biomarkers & Immune Cell Function and Interaction. The author has an h-index of 22, co-authored 54 publications.
ORCID: 0000-0002-3555-616XPapers by this author
worksNF-κB p50 subunit knockout impairs late LTP and alters long term memory in the mouse hippocampus
2012 · BMC Neuroscience · 50 citations
https://doi.org/10.1186/1471-2202-13-45
IgG4-related lung disease showing high standardized uptake values on FDG-PET: report of two cases
2013 · Journal of Cardiothoracic Surgery · 42 citations
https://doi.org/10.1186/1749-8090-8-160
Esophageal schwannoma: a case report
2013 · World Journal of Surgical Oncology · 40 citations
https://doi.org/10.1186/1477-7819-11-253
PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma
2019 · Journal of Translational Medicine · 17 citations
https://doi.org/10.1186/s12967-019-1957-5
Histological grade as an alternative to the Ki67 labeling index is only available for luminal-type breast cancers
2012 · Breast Cancer · 6 citations
https://doi.org/10.1007/s12282-012-0353-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat